drugset / Trial / NCT01935193

Aspirin Resistance Reversibility in Diabetic Patients

NCT01935193

Phase 4 Unknown 160 enrolled Azienda Ospedaliera San Giovanni Battista
NaSingle-groupOpen-labelTreatment

Summary

The aim of the study is assessing the prevalence of aspirin resistance in a cohort of diabetic patients. Those found resistant has been undergone pharmacological tests using different drug formulations to investigate the reversibility of aspirin resistance.

Timeline

Start
2011-11
Primary completion
2013-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject lysine acetylsalicylate Unknown 288 mg Intravenous

Indications